
Pandion Therapeutics, Inc. PAND
Pandion Therapeutics, Inc. Finanzkreislauf | PAND
Finanzkreislauf Jährlich Pandion Therapeutics, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 122 | 25.4 | 3.27 | -22.7 | 27.3 | -75.2 | -100 | -36.6 | -4.05 | 22.7 |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 122 | -100 | -3.85 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Caladrius Biosciences
CLBS
|
966 | - | -16.75 % | $ 25.8 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
-1.6 K | - | -5.98 % | $ 34.1 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-1.6 K | - | -4.36 % | $ 27 M | ||
|
Diffusion Pharmaceuticals
DFFN
|
-1.76 K | - | 11.68 % | $ 8.97 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | - | - | $ 661 M | ||
|
Evofem Biosciences
EVFM
|
-850 | - | 7.55 % | $ 38.1 M | ||
|
Eyenovia
EYEN
|
-1.37 K | - | 49.81 % | $ 13.2 M | ||
|
FibroGen
FGEN
|
-608 | - | - | $ 889 M | ||
|
Amicus Therapeutics
FOLD
|
828 | - | - | $ 4.47 B | ||
|
GlycoMimetics
GLYC
|
303 | - | 9357.83 % | $ 1.01 B | ||
|
Happiness Biotech Group Limited
HAPP
|
-30.4 | - | 1.35 % | $ 17.8 M | ||
|
Novavax
NVAX
|
-79.7 | $ 9.97 | -2.25 % | $ 1.62 B | ||
|
KalVista Pharmaceuticals
KALV
|
-816 | - | - | $ 1.45 B | ||
|
KemPharm
KMPH
|
-73.8 | - | -0.34 % | $ 200 M | ||
|
Kezar Life Sciences
KZR
|
38.3 | - | - | $ 53.3 M | ||
|
NovaBay Pharmaceuticals
NBY
|
28 | - | - | $ 11.3 M | ||
|
OncoCyte Corporation
OCX
|
-224 | - | 17.22 % | $ 355 K | ||
|
Onconova Therapeutics
ONTX
|
364 | - | -0.47 % | $ 21 M | ||
|
Verastem
VSTM
|
-800 | $ 9.17 | 5.04 % | $ 636 M | ||
|
Plus Therapeutics
PSTV
|
-336 M | - | - | $ 301 M | ||
|
Pluristem Therapeutics
PSTI
|
-508 | - | -1.9 % | $ 33.3 M | ||
|
Qualigen Therapeutics
QLGN
|
49.8 | - | 5.59 % | $ 1.16 M | ||
|
Qilian International Holding Group Limited
QLI
|
111 | - | -6.08 % | $ 184 M | ||
|
Sangamo Therapeutics
SGMO
|
4.14 | - | - | $ 50.4 M | ||
|
Salarius Pharmaceuticals
SLRX
|
382 | - | - | $ 2.64 M | ||
|
Sonnet BioTherapeutics Holdings
SONN
|
-545 | - | - | $ 826 K | ||
|
Vaxart
VXRT
|
-5.69 | - | -25.06 % | $ 46.3 M |